166.06 USD
▼+1.84-0.10%
2026-08-03
市值
$16.88B
市盈率
24.35
EPS
6.82
股息率
—
52 周区间
122.14 – 186.12
成交量
1.20M
Beta
0.39
目标价
211.94
52W 低 122.1452W 高 186.12
价格走势
公司简介
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company’s products include INGREZZA for tardive dyskinesia and chorea associated with Huntington’s disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical develo...